FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Carboplatin Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Ingenus Pharmaceuticals LLC (New 02/20/2026)

Company Contact Information:
866-321-5031

Presentation	Posting Date	Related Information
Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)	02/20/2026	Discontinuation of the manufacture of the drug
Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)	02/20/2026	Discontinuation of the manufacture of the drug

Teyro Labs (New 06/01/2026)

Company Contact Information:
Apotex Inc.: 800-706-5575

Presentation	Posting Date	Related Information
Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)	06/01/2026	Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)	06/01/2026	Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)	06/01/2026	Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)	06/01/2026	Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug